Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ZYUS Life SciencesTSXV:ZYUS 16 Days Inventory is 395.64 as of Mar. 2026, which is 82% below its 10-year median of 2,139.59. GuruFocus rates TSXV:ZYUS with a GF Score™ of 16/100. The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, ZYUS Life Sciences ranks worse than 93.07% on this metric.
The historical rank and industry rank for ZYUS Life Sciences's Days Inventory or its related term are showing as below:
TSXV:ZYUS'
s Days Inventory Range Over the Past 10 Years
Min: 427.09 Med: 2139.59 Max: 6330.72
Current: 427.09
During the past 5 years, ZYUS Life Sciences's highest Days Inventory was 6330.72. The lowest was 427.09. And the median was 2139.59.
TSXV:ZYUS's Days Inventory is ranked worse than 93.07% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs TSXV:ZYUS: 427.09
ZYUS Life Sciences's Days Inventory
declined
from Mar. 2025 (1,016.42) to Mar. 2026 (395.64).
Inventory Turnover measures how fast the company turns over its inventory within a year.
ZYUS Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ZYUS Life Sciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.38.
ZYUS Life Sciences (TSXV:ZYUS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ZYUS Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ZYUS Life Sciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ZYUS Life Sciences Days Inventory Related Terms
ZYUS Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for ZYUS Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:ZYUS vs RMTI, BTAI, MRMD: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ZYUS Life Sciences Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where ZYUS Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZYUS Life Sciences (TSXV:ZYUS) has a Days Inventory of 395.64 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ZYUS Life Sciences and its competitors. This is 82% below median its historical median of 2,139.59. Over the past decade, ZYUS Life Sciences' Days Inventory has ranged from 427.09 to 6,330.72. According to the industry distribution chart, ZYUS Life Sciences ranks #859 out of 923 companies in the Drug Manufacturers industry, placing it in the top 93.1%.
Is ZYUS Life Sciences' Days Inventory too high?
ZYUS Life Sciences' current Days Inventory of 395.64 is 82% below median its 10-year median of 2,139.59. Over the past 10 years, this metric has ranged from a low of 427.09 to a high of 6,330.72. The Drug Manufacturers industry median Days Inventory is 164.87. ZYUS Life Sciences' value of 395.64 is 140% above this industry median. Based on the distribution chart, ZYUS Life Sciences ranks #859 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ZYUS Life Sciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ZYUS Life Sciences' Days Inventory compare to RMTI and BTAI?
According to the Drug Manufacturers industry distribution chart, ZYUS Life Sciences ranks #859 out of 923 companies for Days Inventory. This places ZYUS Life Sciences in the lower half of its industry. The industry median Days Inventory is 164.87. ZYUS Life Sciences' value of 395.64 is 140% above this benchmark. Historically, ZYUS Life Sciences' own Days Inventory has ranged from 427.09 to 6,330.72 over the past decade. While the company's 10-year median is 2,139.59 vs. the industry median of 164.87, ZYUS Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ZYUS Life Sciences's current Days Inventory of 395.64 is 140% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ZYUS Life Sciences and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ZYUS Life Sciences's current Days Inventory is 395.64, which is 82% below median its own 10-year median of 2,139.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZYUS Life Sciences stock overvalued right now?
ZYUS Life Sciences (TSXV:ZYUS) has a current Days Inventory of 395.64. The current Days Inventory is 395.64, which is 82% below median its 10-year median of 2,139.59 and 140% above the Drug Manufacturers industry median of 164.87. ZYUS Life Sciences' overall GF Score™ is 16/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ZYUS Life Sciences (TSXV:ZYUS), the current Days Inventory is 395.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ZYUS Life Sciences Corp is primarily engaged in the world-wide development and commercialization of cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada. The company has one reportable segment: Bio-pharmaceutical Products (including medical cannabis derivatives). Geographically, it operates in Canada; United States; Australia; and European Union.
16GF Score
Get the complete analysis for TSXV:ZYUS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:ZYUS has been successfully added to your 
